Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
Boehringer Ingelheim
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Merck Sharp & Dohme LLC
Pfizer
pharmaand GmbH
Jules Bordet Institute
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center